GPS Wealth Strategies Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2
Closed -$778 1673
2025
Q2
$778 Buy
+2
New +$804 ﹤0.01% 1449
2024
Q4
Sell
-30
Closed -$15.6K 1398
2024
Q3
$15.6K Hold
30
﹤0.01% 855
2024
Q2
$16.3K Hold
30
﹤0.01% 804
2024
Q1
$15.6K Hold
30
﹤0.01% 774
2023
Q4
$14.1K Hold
30
﹤0.01% 771
2023
Q3
$13.1K Hold
30
﹤0.01% 788
2023
Q2
$13.3K Hold
30
﹤0.01% 784
2023
Q1
$13.8K Buy
+30
New +$14.3K ﹤0.01% 774
2022
Q4
Sell
-44
Closed -$20K 404
2022
Q3
$20K Sell
44
-26
-37% -$12.4K 0.01% 613
2022
Q2
$34K Buy
+70
New +$34.6K 0.01% 518

Other funds holding ELV

GPS Wealth Strategies Group's ELV Position: Q3 2025 in Review

GPS Wealth Strategies Group sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 2 shares — an estimated $778 sold.

GPS Wealth Strategies Group first reported a position in ELV in Q2 2022 and held it in 10 quarters. The position peaked at $34K in Q2 2022. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • GPS Wealth Strategies Group reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • GPS Wealth Strategies Group sold 2 Elevance Health shares in Q3 2025, an estimated $778.
  • GPS Wealth Strategies Group first reported a position in Elevance Health in Q2 2022 and held it in 10 quarters.
  • GPS Wealth Strategies Group's Elevance Health position peaked at $34K in Q2 2022.
  • 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q3 2025, filed 3 Nov 2025.